CN102526806B - 一种组织工程软骨及其制备方法 - Google Patents
一种组织工程软骨及其制备方法 Download PDFInfo
- Publication number
- CN102526806B CN102526806B CN 201210019026 CN201210019026A CN102526806B CN 102526806 B CN102526806 B CN 102526806B CN 201210019026 CN201210019026 CN 201210019026 CN 201210019026 A CN201210019026 A CN 201210019026A CN 102526806 B CN102526806 B CN 102526806B
- Authority
- CN
- China
- Prior art keywords
- cartilage
- layer
- culture fluid
- tissue
- tissue engineering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000845 cartilage Anatomy 0.000 title claims abstract description 147
- 210000001519 tissue Anatomy 0.000 title claims abstract description 73
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 210000004027 cell Anatomy 0.000 claims abstract description 61
- 102000008186 Collagen Human genes 0.000 claims abstract description 22
- 108010035532 Collagen Proteins 0.000 claims abstract description 22
- 229920001436 collagen Polymers 0.000 claims abstract description 22
- 230000002706 hydrostatic effect Effects 0.000 claims abstract description 11
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 10
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 10
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 9
- 239000012531 culture fluid Substances 0.000 claims description 59
- 210000001612 chondrocyte Anatomy 0.000 claims description 39
- 210000000988 bone and bone Anatomy 0.000 claims description 32
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims description 30
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 26
- 230000002308 calcification Effects 0.000 claims description 24
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 21
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 21
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 21
- 210000002744 extracellular matrix Anatomy 0.000 claims description 21
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 17
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 17
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 17
- 229960003957 dexamethasone Drugs 0.000 claims description 17
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 17
- 230000028327 secretion Effects 0.000 claims description 15
- 238000004113 cell culture Methods 0.000 claims description 13
- 230000001939 inductive effect Effects 0.000 claims description 13
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 12
- 230000015572 biosynthetic process Effects 0.000 claims description 11
- 230000008859 change Effects 0.000 claims description 11
- 210000003035 hyaline cartilage Anatomy 0.000 claims description 11
- 230000004069 differentiation Effects 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 9
- 238000000338 in vitro Methods 0.000 claims description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 8
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 8
- 210000003559 hypertrophic chondrocyte Anatomy 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 210000000963 osteoblast Anatomy 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 210000002950 fibroblast Anatomy 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 4
- 102000004877 Insulin Human genes 0.000 claims description 4
- 108090001061 Insulin Proteins 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- 229940098773 bovine serum albumin Drugs 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 4
- 229940125396 insulin Drugs 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- AVPCPPOOQICIRJ-UHFFFAOYSA-L sodium glycerol 2-phosphate Chemical compound [Na+].[Na+].OCC(CO)OP([O-])([O-])=O AVPCPPOOQICIRJ-UHFFFAOYSA-L 0.000 claims description 4
- 229940054269 sodium pyruvate Drugs 0.000 claims description 4
- 229960001471 sodium selenite Drugs 0.000 claims description 4
- 235000015921 sodium selenite Nutrition 0.000 claims description 4
- 239000011781 sodium selenite Substances 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 2
- 230000035790 physiological processes and functions Effects 0.000 claims description 2
- 210000001258 synovial membrane Anatomy 0.000 claims description 2
- 239000010410 layer Substances 0.000 abstract description 95
- 206010007710 Cartilage injury Diseases 0.000 abstract description 20
- 210000001188 articular cartilage Anatomy 0.000 abstract description 17
- 230000007547 defect Effects 0.000 abstract description 16
- 239000011159 matrix material Substances 0.000 abstract description 8
- 230000008929 regeneration Effects 0.000 abstract description 5
- 238000011069 regeneration method Methods 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 2
- 230000010354 integration Effects 0.000 abstract 2
- 210000003321 cartilage cell Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
- 239000002344 surface layer Substances 0.000 abstract 1
- 230000008439 repair process Effects 0.000 description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 230000006378 damage Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 241001484259 Lacuna Species 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 210000005065 subchondral bone plate Anatomy 0.000 description 6
- 238000007920 subcutaneous administration Methods 0.000 description 6
- 241000699660 Mus musculus Species 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000011580 nude mouse model Methods 0.000 description 5
- 238000002054 transplantation Methods 0.000 description 5
- 208000006735 Periostitis Diseases 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 210000003460 periosteum Anatomy 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000013201 Stress fracture Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000022159 cartilage development Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 210000001162 elastic cartilage Anatomy 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000001582 osteoblastic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 229950003937 tolonium Drugs 0.000 description 2
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000002734 Collagen Type VI Human genes 0.000 description 1
- 108010043741 Collagen Type VI Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- -1 hyaluronic acid compound Chemical class 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004072 osteoblast differentiation Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 210000004285 patellofemoral joint Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000002629 repopulating effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000011540 sensing material Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210019026 CN102526806B (zh) | 2012-01-20 | 2012-01-20 | 一种组织工程软骨及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210019026 CN102526806B (zh) | 2012-01-20 | 2012-01-20 | 一种组织工程软骨及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102526806A CN102526806A (zh) | 2012-07-04 |
CN102526806B true CN102526806B (zh) | 2013-12-18 |
Family
ID=46335610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210019026 Expired - Fee Related CN102526806B (zh) | 2012-01-20 | 2012-01-20 | 一种组织工程软骨及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102526806B (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015523155A (ja) | 2012-07-11 | 2015-08-13 | オシリス セラピューティクス,インコーポレイテッド | 軟骨製品の製造方法 |
CN103920190B (zh) * | 2013-01-14 | 2017-09-29 | 陕西博鸿生物科技集团有限公司 | 一种关节软骨移植物及其制备方法 |
CN104922730A (zh) * | 2015-04-29 | 2015-09-23 | 陕西瑞盛生物科技有限公司 | 一种软骨细胞组织工程材料及其制备方法和用途 |
CN105169485A (zh) * | 2015-07-29 | 2015-12-23 | 西安芙金细胞科技有限公司 | 一种组织工程子宫内膜及其制备方法 |
CN105013016B (zh) * | 2015-07-29 | 2017-12-08 | 东莞芙金干细胞再生医学有限公司 | 一种骨缺损再生修复组织工程骨及其构建方法与应用 |
CN105854085A (zh) * | 2016-04-25 | 2016-08-17 | 上海国睿生命科技有限公司 | 一种体内构建组织工程软骨的方法 |
KR101836475B1 (ko) * | 2016-08-02 | 2018-03-08 | 아주대학교산학협력단 | 연골 재생용 조성물 및 이의 제조방법 |
CN106943630B (zh) * | 2017-03-30 | 2020-04-24 | 四川大学 | 一种体外培育生长出的透明软骨样块状组织及其制备方法和应用 |
CN107469146B (zh) * | 2017-08-02 | 2022-07-05 | 中南大学湘雅医院 | 双相组织工程支架 |
CN111821519A (zh) * | 2019-04-15 | 2020-10-27 | 弗元(上海)生物科技有限公司 | 一种组织工程软骨的制备方法及其应用 |
CN110172443B (zh) * | 2019-05-23 | 2022-07-29 | 中国人民解放军第四军医大学 | 利用骨髓间充质干细胞构建组织工程软骨的方法 |
PL240714B1 (pl) * | 2019-08-02 | 2022-05-23 | Arthec Spolka Z Ograniczona Odpowiedzialnoscia | Sposób prowadzenia hodowli komórkowej chondrocytów in vitro do uzyskiwania materiału do leczenia ubytków chrząstki stawowej |
CN111135344A (zh) * | 2020-02-27 | 2020-05-12 | 福州大学 | 复合白蛋白的碳纳米管/胶原基软骨修复用支架及其制备方法 |
CN112370573B (zh) * | 2020-11-04 | 2023-06-23 | 山东佰傲干细胞生物技术有限公司 | 一种软骨膜片及其制备方法 |
CN112618800B (zh) * | 2020-12-24 | 2022-02-22 | 四川大学 | 一种下颌骨髁突骨软骨修复支架材料及其制备方法 |
CN114854675A (zh) * | 2021-01-20 | 2022-08-05 | 上海软馨生物科技有限公司 | 一种凝胶软骨接种于框架结构实现软骨再生的方法 |
TWI838709B (zh) * | 2021-03-19 | 2024-04-11 | 高雄醫學大學 | 區域分層的軟骨細胞層片的製備方法及其用途 |
CN115581812A (zh) * | 2022-09-29 | 2023-01-10 | 中国人民解放军总医院第一医学中心 | 软骨支架及其制备方法 |
CN115785256A (zh) * | 2022-11-09 | 2023-03-14 | 武汉轻工大学 | 一种调控胶原与细胞受体结合能力的方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080194A (en) * | 1995-02-10 | 2000-06-27 | The Hospital For Joint Disease Orthopaedic Institute | Multi-stage collagen-based template or implant for use in the repair of cartilage lesions |
CN1546654A (zh) * | 2003-12-11 | 2004-11-17 | 西安交通大学 | 一种用骨基质凝胶构建组织工程软骨的方法 |
EP1764117A1 (en) * | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implant for the repair of a cartilage defect and method for manufacturing the implant |
CN101066475A (zh) * | 2007-05-25 | 2007-11-07 | 浙江大学 | 一种软骨组织工程支架及其应用 |
CN101168072A (zh) * | 2006-10-23 | 2008-04-30 | 西安瑞捷生物医疗技术有限公司 | 一种人工骨及其制造方法 |
CN101417151A (zh) * | 2008-07-10 | 2009-04-29 | 中国人民解放军第三军医大学第一附属医院 | 生物源性含钙化层骨软骨组织工程支架 |
EP2110431A1 (en) * | 1997-05-13 | 2009-10-21 | Osiris Therapeutics, Inc. | Cartilage regeneration using human mesenchymal stem cells |
CN101954121A (zh) * | 2010-09-30 | 2011-01-26 | 中国人民解放军第四军医大学 | 软骨缺损修复体、制备方法以及一体化软骨-骨修复材料 |
-
2012
- 2012-01-20 CN CN 201210019026 patent/CN102526806B/zh not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080194A (en) * | 1995-02-10 | 2000-06-27 | The Hospital For Joint Disease Orthopaedic Institute | Multi-stage collagen-based template or implant for use in the repair of cartilage lesions |
EP2110431A1 (en) * | 1997-05-13 | 2009-10-21 | Osiris Therapeutics, Inc. | Cartilage regeneration using human mesenchymal stem cells |
CN1546654A (zh) * | 2003-12-11 | 2004-11-17 | 西安交通大学 | 一种用骨基质凝胶构建组织工程软骨的方法 |
EP1764117A1 (en) * | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implant for the repair of a cartilage defect and method for manufacturing the implant |
CN101168072A (zh) * | 2006-10-23 | 2008-04-30 | 西安瑞捷生物医疗技术有限公司 | 一种人工骨及其制造方法 |
CN101066475A (zh) * | 2007-05-25 | 2007-11-07 | 浙江大学 | 一种软骨组织工程支架及其应用 |
CN101417151A (zh) * | 2008-07-10 | 2009-04-29 | 中国人民解放军第三军医大学第一附属医院 | 生物源性含钙化层骨软骨组织工程支架 |
CN101954121A (zh) * | 2010-09-30 | 2011-01-26 | 中国人民解放军第四军医大学 | 软骨缺损修复体、制备方法以及一体化软骨-骨修复材料 |
Also Published As
Publication number | Publication date |
---|---|
CN102526806A (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526806B (zh) | 一种组织工程软骨及其制备方法 | |
Hung et al. | Anatomically shaped osteochondral constructs for articular cartilage repair | |
Ebihara et al. | Cartilage repair in transplanted scaffold-free chondrocyte sheets using a minipig model | |
Yin et al. | Induction of mesenchymal stem cell chondrogenic differentiation and functional cartilage microtissue formation for in vivo cartilage regeneration by cartilage extracellular matrix-derived particles | |
Bouten et al. | Substrates for cardiovascular tissue engineering | |
Mikos et al. | Engineering complex tissues | |
EP2522304B1 (en) | Composition and methods for the production of biological tissues and tissue constructs | |
Renth et al. | Leveraging “raw materials” as building blocks and bioactive signals in regenerative medicine | |
Mhanna et al. | Introduction to tissue engineering | |
US8734827B2 (en) | Bioengineered intervertebral discs and methods for their preparation | |
CN101053679B (zh) | 一种纤维蛋白凝胶填充的聚合物多孔支架的制备方法 | |
US20020106625A1 (en) | Bioreactor for generating functional cartilaginous tissue | |
Hasan | Tissue engineering for artificial organs: regenerative medicine, smart diagnostics and personalized medicine | |
CN101979105A (zh) | 一种用于软骨缺损修复的组织工程支架材料及其制备方法 | |
Li et al. | Collagen-based bioinks for regenerative medicine: Fabrication, application and prospective | |
CN104056304B (zh) | 负载生长因子壳聚糖微球的dbm支架修复关节软骨材料 | |
Lv et al. | Repair of articular osteochondral defects of the knee joint using a composite lamellar scaffold | |
Schmidt et al. | Tissue-engineered heart valves | |
US11786636B2 (en) | Methods for complex tissue engineering | |
Martin et al. | Producing prefabricated tissues and organs via tissue engineering | |
Namdari et al. | Paediatric nanofibrous bioprosthetic heart valve | |
Wu et al. | Engineering cartilage tissues with the shape of human nasal alar by using chondrocyte macroaggregate—experiment study in rabbit model | |
Chen et al. | Effects of collagen-based nano-biomaterials on the health of lower limb joint sports | |
Quint et al. | Tissue engineering and regenerative medicine | |
Chen et al. | Collagen-based scaffolds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHAANXI BOAO REGENERATION MEDICAL CO., LTD. Free format text: FORMER OWNER: SHAANXI BOHONG BIOTECHNOLOGY CO., LTD. Effective date: 20141115 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Yongjie Inventor after: Yang Lu Inventor after: Huang Wentao Inventor after: Zhang Lijuan Inventor before: Tian Zhiquan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: TIAN ZHIQUAN TO: ZHANG YONGJIE YANG LU HUANG WENTAO ZHANG LIJUAN Free format text: CORRECT: ADDRESS; FROM: 710065 XI'AN, SHAANXI PROVINCE TO: 727100 TONGCHUAN, SHAANXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141115 Address after: 727100 No. five, Datang eight, New District, Shaanxi, Tongchuan Patentee after: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Address before: 710065 Shaanxi City, south of the Second Ring Road, Qinglong District Albert urban vision, building 11003, No. 1, No. Patentee before: SHAANXI BOHONG BIOTECHNOLOGY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tissue engineering cartilage and preparation method thereof Effective date of registration: 20151221 Granted publication date: 20131218 Pledgee: Xianyang financing Company Limited by Guarantee Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2015990001138 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170113 Granted publication date: 20131218 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2015990001138 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20170113 Registration number: 2015990001138 Pledgee after: Xianyang financing guarantee Limited by Share Ltd. Pledgee before: Xianyang financing Company Limited by Guarantee |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tissue engineering cartilage and preparation method thereof Effective date of registration: 20170420 Granted publication date: 20131218 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2017990000327 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180611 Granted publication date: 20131218 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2017990000327 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tissue engineering cartilage and preparation method thereof Effective date of registration: 20180611 Granted publication date: 20131218 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2018990000439 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190701 Granted publication date: 20131218 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2018990000439 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tissue engineering cartilage and preparation method thereof Effective date of registration: 20190701 Granted publication date: 20131218 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2019990000643 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200915 Granted publication date: 20131218 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2019990000643 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A tissue engineering cartilage and its preparation method Effective date of registration: 20200915 Granted publication date: 20131218 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: Y2020990001114 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211119 Granted publication date: 20131218 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: Y2020990001114 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131218 |